AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 49 filers reported holding AKERO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,780,607 | -0.9% | 1,419,150 | -8.5% | 1.92% | +11.6% |
| Q2 2023 | $72,404,704 | +30.1% | 1,550,754 | +6.6% | 1.72% | +29.7% |
| Q1 2023 | $55,639,758 | -27.5% | 1,454,254 | +3.8% | 1.33% | -28.1% |
| Q4 2022 | $76,755,839 | +64.5% | 1,400,654 | +2.2% | 1.85% | +53.3% |
| Q3 2022 | $46,648,000 | +626.5% | 1,369,973 | +101.6% | 1.20% | +544.4% |
| Q2 2022 | $6,421,000 | -28.8% | 679,514 | +7.0% | 0.19% | -17.6% |
| Q1 2022 | $9,014,000 | -27.4% | 635,214 | +8.2% | 0.23% | -20.9% |
| Q4 2021 | $12,417,000 | -2.3% | 587,101 | +3.2% | 0.29% | +7.5% |
| Q3 2021 | $12,710,000 | -3.1% | 568,701 | +7.6% | 0.27% | +3.1% |
| Q2 2021 | $13,115,000 | -13.3% | 528,601 | +1.4% | 0.26% | -21.5% |
| Q1 2021 | $15,119,000 | +13.7% | 521,171 | +1.1% | 0.33% | +17.0% |
| Q4 2020 | $13,297,000 | +2.1% | 515,371 | +21.8% | 0.28% | -14.5% |
| Q3 2020 | $13,025,000 | +115.1% | 423,040 | +74.1% | 0.33% | +98.8% |
| Q2 2020 | $6,055,000 | +26.9% | 242,985 | +8.0% | 0.17% | -15.7% |
| Q1 2020 | $4,770,000 | -4.5% | 225,000 | 0.0% | 0.20% | +24.7% |
| Q4 2019 | $4,994,000 | -2.4% | 225,000 | 0.0% | 0.16% | -22.5% |
| Q3 2019 | $5,119,000 | +18.8% | 225,000 | 0.0% | 0.20% | +30.8% |
| Q2 2019 | $4,309,000 | – | 225,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
| venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
| Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
| Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
| Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
| Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
| Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
| Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
| HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |